Imaging Vascular Infection and Inflammation by FDG-PET/CT or Radiolabelled White Blood Cells
A special issue of Hemato (ISSN 2673-6357). This special issue belongs to the section "Radiolabeled Blood Elements and Other Imaging Modalities".
Deadline for manuscript submissions: closed (15 November 2023) | Viewed by 1064
Interests: nuclear medicine; infection imaging; inflammation imaging; thyroid cancer imaging; pre-clinical imaging; imaging immuno-therapy; imaging autoimmune diseases
Special Issues, Collections and Topics in MDPI journals
Interests: nuclear medicine; PET/CT; inflammation/infection imaging; thyroid cancer imaging and therapy; neuroendocrine tumor imaging and therapy; lymphoma imaging; multiple myeloma imaging
This Special Issue aims at providing a panoramic overview of current and future strategies for imaging vascular infections and inflammation. Both conditions still represent a challenge for clinicians and require a prompt diagnosis and initiation of adequate treatment.
Nuclear medicine imaging has rapidly gained a role in the field of infection and inflammation, and it is currently included in most of the diagnostic flowcharts for the diagnosis of vasculitis, vascular graft infections and cardiovascular infections. For some of these indications, specific interpretation criteria, able to allow an accurate diagnosis, have been published for both [18F]FDG PET/CT and radiolabelled white blood cells scintigraphy, thereby improving therapy planning; for some other clinical indications, standardized protocols of image acquisition and interpretation are still needed and deserve further prospective and comparative studies.
This Special Issue will be, therefore, focused on the possible application of [18F]FDG PET/CT and radiolabelled white blood cells scintigraphy for imaging atherosclerosis, vasculitis, vascular graft infections and other haematological conditions. In particular, it will collect papers exploring the potential of nuclear medicine imaging in the diagnostic setting of these situations as well as for monitoring disease activity after a proper treatment.
Prof. Dr. Alberto Signore
Dr. Annibale Versari
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Hemato is an international peer-reviewed open access quarterly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1000 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- radiolabelled white blood cells
- vascular grafts
- haematological disorders